Trial Profile
Efficacy of treatment with Ospemifene on glycogen content, proliferation index, epithelium thickness, and estrogen receptor alpha (ERα) expression of the vaginal tissue of post-menopausal women
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 30 Jul 2018
Price :
$35
*
At a glance
- Drugs Ospemifene (Primary)
- Indications Atrophic vaginitis
- Focus Therapeutic Use
- 22 Apr 2017 New trial record
- 04 Apr 2017 Results presented at The 99th Annual Meeting of the Endocrine Society